It's been a big day for COVID boosters.
Tuesday afternoon, the Centers for Disease Control and Prevention followed the Food and Drug Administration in clearing a new round of Moderna or Pfizer-BioNTech COVID-19 boosters for Americans ages 50 and older, CBS News reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Data released by the CDC shortly before the decision to authorize the second booster showed those who received the single-shot J&J regimen to be at a greater risk of serious hospitalization and illness than those who received the mRNA vaccines, reports the Post. The CDC strongly recommends those populations consider getting a booster dose of either the Pfizer or Moderna vaccine, per The Hill.
The second booster is "especially important for those 65 and older and those 50 and older with underlying medical conditions that increase their risk for severe disease from COVID-19 as they are the most likely to benefit from receiving an additional booster dose at this time," said CDC Director Rochelle Walensky, per The Wall Street Journal.
The FDA and CDC also authorized a second Pfizer booster for immunocompromised individuals ages 12 and up who've received their first COVID booster, and a second Moderna booster for immunocompromised people ages 18 and above, the Journal notes.
The decisions arrive as as the Omicron subvariant BA.2 continues to gain ground in the U.S.
-
Critics' choice: Outstanding new Japanese restaurantsFeature An all-women sushi team, a 15-seat listening bar, and more
-
Why do Dana White and Donald Trump keep pushing for a White House UFC match?TODAY'S BIG QUESTION The president and the sports mogul each have their own reasons for wanting a White House spectacle
-
'Quiet vacationing': a secret revolt against workplace cultureThe explainer You can be in two places at once
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
